Lactate‐induced metabolic reprogramming of TAMs impairs antigen presentation capacity via C/EBPα–CD74 axis in oral squamous cell carcinoma
Clinical and Translational Medicine · 2026
DOI: 10.1002/ctm2.70639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2026. Verfasst von Mengyao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Science of Stomatology, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Histocompatibility Antigens Class II, Antigens, Differentiation, B-Lymphocyte, Antigen Presentation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Nature Science Foundation of Jiangsu Province, Jiangsu Provincial Research Hospital Cultivation Unit.
Abstract (Originalsprache)
Background
Throughout oral squamous cell carcinoma (OSCC) progression, tumor‐associated macrophages (TAMs) lose their antigen‐presenting capacity and anti‐tumor function. The mechanisms that cause this dysfunction are not fully understood. CD74 is essential for antigen‐presenting process, while little direct evidence describes its role in TAMs' immune function.
Methods
We integrated single‐cell transcriptomic analysis, clinical cohort validation and CD74 conditional knockout mouse model to investigate the role of CD74 in TAMs during OSCC progression. Metabolomic analysis and mechanistic studies were performed to dissect how lactate‐mediated metabolic reprogramming regulates CD74 expression.
Results
We demonstrate that lactate accumulation in TME induces metabolic reprogramming of TAMs, which drives the acetylation of C/EBPα, and consequently suppresses CD74 expression. This downregulation of CD74 impairs the antigen‐presenting capacity of TAMs, suppresses T cell activation, and ultimately promotes OSCC progression and recurrence.
Conclusions
Our findings reveal the critical role of the lactate‐C/EBPα‐CD74 axis in shaping TAMs function, and provide potential therapeutic target for OSCC immunotherapy. Key points CD74 hi TAMs decrease during OSCCprogression and are associated with patient prognosis. Loss of CD74 impairs antigen presentation andsuppresses T cell activation. Tumor‐derived lactateinhibits CD74 transcription via C/EBPα acetylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Science of Stomatology, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.
- State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing Medical University, Nanjing, China.
- Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing Medical University, Nanjing, China.
- Department of Oral Mucosal Diseases, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.
Förderung
- National Natural Science Foundation of China
- Nature Science Foundation of Jiangsu Province
- Jiangsu Provincial Research Hospital Cultivation Unit
- Jiangsu Provincial Medical Innovation Center
Zitieren
APA
Wang, M., Wang, M., Gong, Z., Zeng, F., Ni, Z., Zhai, R., Zhu, W., Zhang, J., & Liu, L. (2026). Lactate‐induced metabolic reprogramming of TAMs impairs antigen presentation capacity via C/EBPα–CD74 axis in oral squamous cell carcinoma. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70639
Vancouver
Wang M, Wang M, Gong Z, Zeng F, Ni Z, Zhai R, et al. Lactate‐induced metabolic reprogramming of TAMs impairs antigen presentation capacity via C/EBPα–CD74 axis in oral squamous cell carcinoma. Clinical and Translational Medicine. 2026. doi:10.1002/ctm2.70639
BibTeX
@article{Wang2026,
author = {Wang, Mengyao and Wang, Mengqi and Gong, Zizhen and Zeng, Fanrui and Ni, Zihui and Zhai, Rundong and Zhu, Weiwen and Zhang, Jiayi and Liu, Laikui},
title = {Lactate‐induced metabolic reprogramming of TAMs impairs antigen presentation capacity via C/EBPα–CD74 axis in oral squamous cell carcinoma},
journal = {Clinical and Translational Medicine},
year = {2026},
doi = {10.1002/ctm2.70639}
}
EUVIMED